Urine antibody tests: New insights into the dynamics of HIV-I infection

Clinical Chemistry

Volumn 45, Issue 9, 1999, Pages 1602-1613

  Urnovitz, Howard B ^a   Sturge, Jerrilyn C ^a   Gottfried, Toby D ^a   Murphy, William H ^b  

^a Calypte Biomedical Corporation   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

CHROMOSOME 7Q; CONFERENCE PAPER; DIAGNOSTIC VALUE; ENZYME IMMUNOASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; URINALYSIS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0032880774     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/45.9.1602     Document Type: Conference Paper

References (49)

1. Barre-Sinoussi F, Chermann JC, Ray F, Nugeyre MT, Chamaret S, Gruest J, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983;220:868-71.
2. Cao Y, Friedman-Kien AE, Chuba JV, Mirabile M, Hosein B. IgG antibodies to HIV-1 in urine of HIV-1 seropositive individuals. Lancet 1988;1:831-2.
3. Urnovitz HB, Tuite JJ, Higashida JM, Murphy WH. RNAs in the sera of Persian Gulf War veterans have segments homologous to chromosome 22q11.2. Clin Diagn Lab Immunol 1999;6:330-5.
4. Hausler WJ Jr. Report of the Third Consensus Conference on HIV testing sponsored by the Association of State and Territorial Public Health Laboratory Directors. Infect Control Hosp Epidemiol 1988;9:345-9.
5. Urnovitz HB, Sturge JC, Gottfried TD. Increased sensitivity of HIV-1 antibody detection. Nat Med 1997;3:1258.
6. Hurlstone AF, Reid G, Reeves JR, Fraser J, Strathdee G, Rahilly M, et al. Analysis of the CAVEOLIN-1 gene at human chromosome 7q31.1 in primary tumours and tumour-derived cell lines. Oncogene 1999;18:1881-90.
7. Huang H, Qian J, Proffit J, Wilber K, Jenkins R, Smith DI. FRA7G extends over a broad region: coincidence of human endogenous retroviral sequences (HERV-H) and Small polydispersed circular DNAs [spcDNA) and fragile sites. Oncogene 1998;16:2311-9.
8. Latil A, Cussenot O, Fournier G, Baron JC, Lidereau R. Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer. Clin Cancer Res 1995;1:1385-9.
9. Koike M, Tasaka T, Spira S, Tsuruoka N, Koeffler HP. Allelotyping of acute myelogenous leukemia: less of heterozygosity at 7q31.1 (D7S486) and q33-34 (D7S498, D7S505). Leuk Res 1999;23: 307-10.
10. Sullivan PS, Schable C, Koch W, Do AN, Spire T, Lansky A, et al. Persistently negative HIV-1 antibody enzyme immunoassay screening results for patients with HIV-1 infection and AIDS: serologic, clinical, and virologic results. AIDS 1999;13:89-96.
11. Urnovitz HB, Murphy WH. Human endogenous retroviruses: nature, occurrence, and clinical implications in human disease. Clin Microbiol Rev 1996;9:72-99.
12. Via CS, Morse HC, Shearer GM. Altered immunoregulation and autoimmune aspects of HIV infection: relevant murine models. Immunol Today 1990;11:250-5.
13. Clerici M, Levin JM, Kessler HA, Harris A, Berzofsky JA, Landay AL, et al. HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood. JAMA 1994;271:42-6.
14. Clerici M, Giorgi JV, Chou CC, Gudeman VK, Zack JA, Gupta P, et al. Cell-mediated immune response to human immunodeficiency virus (HIV) type I in seronegative homosexual men with recent sexual exposure to HIV-1. J Infect Dis 1992;165:1012-9.
15. Clerici M, Berzofsky JA, Shearer GM, Tacket CO. Exposure to human immunodeficiency virus (HIV) type I indicated by HIV. specific T helper cell responses before detection of infection by polymerase chain reaction and serum antibodies. J Infect Dis 1991;164:178-82.
16. Pinto LA, Sullivan J, Berzofsky JA, Clerici M, Kessler HA, Landay AL, et al. ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids. J Clin Investig 1995;96:867-76.
17. Mazzoli S, Trabattoni D, Lo Caputo S, Piconi S, Ble C, Meacci F, et al. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nat Med 1997;3:1250-7.
18. Rowland-Jones S, Sutton J, Ariyoshi K, Dong T, Gotch F, McAdam S, et al. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat Med 1995;1:59-64.
19. Kaul R, Trabattoni D, Bwayo JJ, Arienti D, Zagliani A, Mwangi FM, et al. HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers. AIDS 1999;13:23-9.
20. Garry RF. Extensive antigenic mimicry by retrovirus capsid proteins. AIDS Res Hum Retroviruses 1990;6:1361-2.
21. Kulberg AJ. Structural homology between HIV-1 tat protein and various human proteins. AIDS Res Hum Retroviruses 1990;6:1059-60.
22. Bisset LR. Molecular mimicry in the pathogenesis of AIDS: the HIV/MHC/mycoplasma triangle. Med Hypotheses 1994;43:388-96.
23. Shearer GM, Bernstein DC, Tung KSK, Via CS, Redfield R, Salahuddin SZ, et al. A model for the selective boss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS). J Immunol 1986;137:2514-21.
24. Underdown BJ, Schiff JM. Immunoglobulin A: strategic defense initiative at the mucosal surface. Annu Rev Immunol 1986;4:389-417.
25. Hanson LA, Ahlstedt S, Andersson B, Carlsson B, Cole MF, Cruz JR, et al. Mucosal immunity. Ann N Y Acad Sci 1983;409:1-21.
26. Pudney J, Anderson DJ. Immunobiology of the human penile urethra. Am J Pathol 1995;147:155-65.
27. Brandtzaeg P. Mucosal immunity in the female genital tract. J Reprod Immunol 1997;36:23-50.
28. Miller CJ, McGhee JR, Gardner MB. Mucosal immunity, HIV transmission, and AIDS. Lab Investig 1993;68:129-45.
29. Shearer GM, Clerici M. Protective immunity against HIV infection: has nature done the experiment for us? Immunol Today 1996;17:21-4.
30. Beyrer C, Artenstein AW, Rugpao S, Stephens H, Van Cott TC, Robb ML, et al. Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. J Infect Dis 1999;179:59-67.
31. Belec L, Tevi-Benissan C, Gresenguet G, Meillet D, Pillot J. HIV-1 antibody serum negativity with vaginal secretions positivity. Lancet 1994;343:1046-7.
32. Bomsel M, Heyman M, Hocini H, Lagaye S, Belec L, Dupont C, et al. Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dlgA or IgM. Immunity 1998;9:277-87.
33. Mazanec MB, Kaetzel CS, Lamm ME, Fletcher D, Nedrud JG. Intracellular neutralization of virus by immunoglobulin A antibodies. Proc Natl Acad Sci U S A 1992;89:6901-5.
34. Mazanec MB, Nedrud JG, Kaetzel CS, Lamm ME. A three-tiered view of the role of IgA in mucosal defense. Immunol Today 1993;14:430-5.
35. Clerici M, Shearer GM. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol Today 1994;15:575-81.
36. Koga Y, Lindstrom E, Fenyo EM, Wigzell H, Mak TW. High levels of heterodisperse RNAs accumulate in T cells infected with human immunodeficiency virus and in normal thymocytes. Proc Natl Acad Sci U S A 1988;85:4521-5.
37. Kiessling AA, Fitzgerald LM, Zhang D, Chhay H, Brettler D, Eyre RC, et al. Human immunodeficiency virus in semen arises from a genetically distinct virus reservoir. AIDS Res Hum Retroviruses 1998;14(Suppl 1):S33-41.
38. Katz RA, Skalka AM. Generation of diversity in retroviruses. Annu Rev Genet 1990;24:409-45.
39. Robertson DL, Sharp PM, McCutchan FE, Hahn BH. Recombination in HIV-1. Nature 1995;374:124-6.
40. Ramos A, Tanuri A, Schechter M, Rayfield MA, Hu DJ, Cabral MC, et al. Dual and recombinant infections: an integral part of the HIV-1 epidemic in Brazil. Emerg Infect Dis 1999;5:65-74.
41. Patterson BK, Landay A, Andersson J, Brown C, Behbahani H, Jiyamapa D, et al. Repertoire of chemokine receptor expression in the female genital tract: implications for human immunodeficiency virus transmission. Am J Pathol 1998;153:481-90.
42. Fisher AG, Ensoli B, Looney D, Rose A, Gallo RC, Saag MS, et al. Biologically diverse, molecular variants within a single HIV-1 isolate. Nature 1988;334:444-7.
43. Poss M, Martin HL, Kreiss JK, Granville L, Chohan B, Nyange P, et al. Diversity in virus populations from genital secretions and peripheral blood from women recently infected with human immunodeficiency virus type 1. J Virol 1995;69:8118-22.
44. Zhu T, Wang N, Carr A, Nam DS, Moor-Jankowski R, Cooper DA, et al. Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission. J Virol 1996; 70:3098-107.
45. Epstein LG, Kuiken C, Blumberg BM, Hartman S, Sharer LR, Clement M, et al. HIV-1 V3 domain variation in brain and spleen of children with AIDS: tissue-specific evolution within host-determined quasispecies. Virology 1991;180;583-90.
46. Artenstein AW, Van Cott TC, Mascola JR, Carr JK, Hegerich PA. Gaywee J, et al. Dual infection with human immunodeficiency virus type 1 of distinct envelope subtypes in humans. J Infect Dis 1995;171:805-10.
47. Charneau P, Borman AM, Quillent C, Guetard D, Chamaret S, Cohen J, et al. Isolation and envelope sequence of a highly divergent HIV-1 isolate: definition of a new HIV-1 group. Virology 1994;205:247-53.
48. Urnovitz HB, Stevens RW. AIDS research priorities. Science 1995; 267:1249-50.
49. Urnovitz HB, Murphy WH. Human endogenous retroviruses. Clin Microbiol Rev 1996;9:585.